Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting

(NASDAQ:WALD), NEW YORK, Nov. 16, 2025 (GLOBE NEWSWIRE) — Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD), today announced new data shared at the recent American Society for Dermatologic Surgery (ASDS) Annual Meeting, which took place November 13-16, 2025, in Chicago, Illinois. Pivotal FDA Study […]

Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting

Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting Obagi(R) saypha(R) ChIQ(TM) data selected as a top 10 cosmetic oral abstract presentation GlobeNewswire November 16, 2025 NEW YORK, Nov. 16, 2025 (GLOBE NEWSWIRE) — Obagi Medical, a leading innovator

BexBack Launches $100 Welcome Bonus and 100% Deposit Match as It Expands 100x Crypto Futures Trading Program

SINGAPORE, Nov. 16, 2025 (GLOBE NEWSWIRE) — BexBack Exchange today announced the official launch of its new promotional trading program, featuring a $100 welcome bonus for new users, a 100% deposit bonus, and access to 100x leverage on crypto futures. With Bitcoin hovering below $110,000 and market volatility surging, the platform aims to give traders

BexBack Launches $100 Welcome Bonus and 100% Deposit Match as It Expands 100x Crypto Futures Trading Program

BexBack Launches $100 Welcome Bonus and 100% Deposit Match as It Expands 100x Crypto Futures Trading Program GlobeNewswire November 16, 2025 SINGAPORE, Nov. 16, 2025 (GLOBE NEWSWIRE) — BexBack Exchange today announced the official launch of its new promotional trading program, featuring a $100 welcome bonus for new users, a 100% deposit bonus, and access

Securities Class Action Lawsuit Filed Against WPP plc (WPP) – Levi & Korsinsky Represents Shareholders

NEW YORK, NY / ACCESS Newswire / November 15, 2025 / If you suffered a loss on your WPP plc (NYSE:WPP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/wpp-plc-lawsuit-submission-form?prid=177550&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Levi & Korsinsky Investigates Zimmer Biomet Holdings, Inc. (ZBH) Over Possible Securities Fraud

NEW YORK, NY / ACCESS Newswire / November 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zimmer Biomet Holdings, Inc. ("Zimmer Biomet Holdings, Inc.") (NYSE:ZBH) concerning possible violations of federal securities laws. Zimmer Biomet issued a press release on November 5, 2025, announcing its financial results for the

Levi & Korsinsky Investigates Alector, Inc. (ALEC) Over Possible Securities Fraud

NEW YORK, NY / ACCESS Newswire / November 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alector, Inc. ("Alector, Inc.") (NASDAQ:ALEC) concerning possible violations of federal securities laws. On October 22, 2025, Alector announced results from its Phase 2 INFRONT-3 clinical trial evaluating latozinemab (AL001) in patients with

Lost Money on WPP plc (WPP)? Contact Levi & Korsinsky to Join Class Action Before December 8, 2025

NEW YORK, NY / ACCESS Newswire / November 15, 2025 / If you suffered a loss on your WPP plc (NYSE:WPP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/wpp-plc-lawsuit-submission-form?prid=177533&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Recover Investment Losses: Class Action Initiated Against Synopsys, Inc. (SNPS)

NEW YORK, NY / ACCESS Newswire / November 15, 2025 / If you suffered a loss on your Synopsys, Inc. (NASDAQ:SNPS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/synopsys-inc-lawsuit-submission-form?prid=177548&wire=1&utm_campaign=24 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Scroll to Top